The Allstate Co. (NYSE:ALL) Given Average Rating of “Moderate Buy” by Analysts

Shares of The Allstate Co. (NYSE:ALLGet Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the seventeen research firms that are presently covering the stock, MarketBeat.com reports. One research analyst has rated the stock with a sell recommendation, three have issued a hold recommendation, twelve have issued a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1-year price target among brokers that have covered the stock in the last year is $174.18.

Several analysts recently issued reports on ALL shares. Jefferies Financial Group raised Allstate from a “hold” rating to a “buy” rating and raised their price target for the stock from $130.00 to $180.00 in a report on Tuesday, January 9th. TD Cowen assumed coverage on shares of Allstate in a research report on Wednesday, January 10th. They set an “outperform” rating and a $193.00 price target for the company. Roth Mkm increased their price objective on shares of Allstate from $175.00 to $200.00 and gave the stock a “buy” rating in a report on Monday, April 8th. Morgan Stanley upped their target price on shares of Allstate from $187.00 to $190.00 and gave the stock an “overweight” rating in a research report on Monday, April 15th. Finally, Keefe, Bruyette & Woods raised their price target on shares of Allstate from $181.00 to $189.00 and gave the company an “outperform” rating in a research note on Wednesday, April 10th.

Check Out Our Latest Report on Allstate

Insider Buying and Selling

In other news, insider John E. Dugenske sold 31,000 shares of the firm’s stock in a transaction dated Tuesday, March 26th. The shares were sold at an average price of $170.20, for a total transaction of $5,276,200.00. Following the completion of the transaction, the insider now owns 63,731 shares in the company, valued at approximately $10,847,016.20. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. In other news, insider John E. Dugenske sold 31,000 shares of the stock in a transaction on Tuesday, March 26th. The stock was sold at an average price of $170.20, for a total transaction of $5,276,200.00. Following the completion of the sale, the insider now owns 63,731 shares in the company, valued at approximately $10,847,016.20. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CAO John C. Pintozzi sold 4,000 shares of the firm’s stock in a transaction on Tuesday, February 27th. The stock was sold at an average price of $159.47, for a total value of $637,880.00. Following the sale, the chief accounting officer now directly owns 10,736 shares of the company’s stock, valued at $1,712,069.92. The disclosure for this sale can be found here. 1.80% of the stock is owned by corporate insiders.

Institutional Trading of Allstate

Several institutional investors and hedge funds have recently bought and sold shares of ALL. 9258 Wealth Management LLC raised its holdings in shares of Allstate by 4.1% during the first quarter. 9258 Wealth Management LLC now owns 10,450 shares of the insurance provider’s stock valued at $1,808,000 after acquiring an additional 416 shares during the period. Buck Wealth Strategies LLC purchased a new position in Allstate during the 1st quarter worth approximately $3,457,000. Affinity Investment Advisors LLC acquired a new stake in Allstate during the 1st quarter valued at $310,000. Csenge Advisory Group purchased a new stake in shares of Allstate in the first quarter valued at $213,000. Finally, Avidian Wealth Solutions LLC boosted its position in shares of Allstate by 21.4% in the first quarter. Avidian Wealth Solutions LLC now owns 4,803 shares of the insurance provider’s stock worth $831,000 after buying an additional 847 shares during the period. Institutional investors and hedge funds own 76.47% of the company’s stock.

Allstate Stock Performance

Shares of ALL opened at $168.18 on Friday. The company has a debt-to-equity ratio of 0.51, a current ratio of 0.37 and a quick ratio of 0.37. Allstate has a 12-month low of $100.57 and a 12-month high of $177.37. The business’s fifty day moving average price is $165.88 and its 200 day moving average price is $150.65. The stock has a market capitalization of $44.24 billion, a PE ratio of 37.13, a price-to-earnings-growth ratio of 0.41 and a beta of 0.51.

Allstate (NYSE:ALLGet Free Report) last posted its quarterly earnings results on Thursday, May 2nd. The insurance provider reported $5.13 EPS for the quarter, beating the consensus estimate of $4.11 by $1.02. The business had revenue of $15.26 billion during the quarter, compared to analyst estimates of $12.76 billion. Allstate had a net margin of 2.31% and a return on equity of 15.14%. The company’s quarterly revenue was up 10.7% on a year-over-year basis. During the same period in the previous year, the business posted ($1.30) EPS. Equities research analysts forecast that Allstate will post 13.83 EPS for the current year.

Allstate Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Monday, April 1st. Stockholders of record on Monday, March 4th were issued a $0.92 dividend. This is a positive change from Allstate’s previous quarterly dividend of $0.89. The ex-dividend date was Friday, March 1st. This represents a $3.68 annualized dividend and a dividend yield of 2.19%. Allstate’s dividend payout ratio is 81.24%.

Allstate Company Profile

(Get Free Report

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.

Featured Stories

Analyst Recommendations for Allstate (NYSE:ALL)

Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.